Human IgG4 Antibody

48305-100ul 100ul
EUR 399.6

Human Antibody Laboratories manufactures the anti human igg4 antibody reagents distributed by Genprice. The Anti Human Igg4 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Anti products are available in stock. Specificity: Anti Category: Human Group: Igg4 Antibody

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

20 ug
EUR 153.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

20 ug
EUR 153.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

IgG4 Antibody

100ul
EUR 399.6

Igg4 Antibody information

Mouse Anti Human Igg4 Monoclonal Antibody

CABT-48879MH 0.2 mg
EUR 1057.2

Human IgG4 Fc Antibody

R20191-100UG 100ug
EUR 347.65
Description: This recombinant Human IgG4 Fc antibody reacts to the Fc region of hIgG4. No cross reactivity with human IgG1, IgG2, IgG3, IgM, IgA, IgD, IgE, mouse/rat/goat IgG.

Human IgG4 Fc Antibody

R20191BTN-50UG 50ug
EUR 347.65
Description: This recombinant Human IgG4 Fc antibody reacts to the Fc region of human IgG4. No cross reactivity with human IgG1, IgG2, IgG3, IgM, IgA, IgD, IgE, mouse IgG, rat IgG, or goat IgG.

Human IgG4 Fc Antibody

R20191SAF-250UG 250ug
EUR 832.15
Description: This recombinant Human IgG4 Fc antibody reacts to the Fc region of hIgG4. No cross reactivity with human IgG1, IgG2, IgG3, IgM, IgA, IgD, IgE, mouse/rat/goat IgG.

Anti-PD-1 (Sintilimab), Human IgG4 Antibody

A2156-100 100 µg
EUR 612

Anti-TNF alpha (Humicade), Human IgG4 Antibody

A1093-200 each
EUR 874.8

Anti-IL-4Rα (Dupilumab), Human IgG4 Antibody

A2148-100 100 µg
EUR 612

Mouse anti-Human IgG4 Antibody

abx401164-05mg 0.5 mg
EUR 794.4

Mouse anti-Human IgG4 Antibody

abx401328-02mg 0.2 mg
EUR 678

Mouse Anti-Human IgG4 antibody

STJ99557-100l 100 µl
EUR 214.8
Description: Unconjugated Mouse monoclonal to Human IgG4 antibody

Mouse Anti-Human IgG4 antibody

STJ99557-1mL 1 mL
EUR 1438.8
Description: Unconjugated Mouse monoclonal to Human IgG4 antibody

Mouse Anti Human Igg4 Monoclonal Antibody,HRP

CABT-48878MH 0.2 mg
EUR 1431.6

Human IgG4 Conjugated Antibody

C48305 100ul
EUR 476.4

Mouse Anti-Human IgG4 (Fc) Antibody

abx023364-5mg 5 mg
EUR 2631.6

Mouse Anti-Human IgG4 (Fc) Antibody

abx023387-1mg 1 mg
EUR 718.8

Mouse Anti-Human IgG4 antibody (AU)

STJ99395-100l 100 µl
EUR 116.4
Description: AU conjugated Mouse monoclonal to Human IgG4

Mouse Anti-Human IgG4 antibody (AU)

STJ99395-1mL 1 mL
EUR 560.4
Description: AU conjugated Mouse monoclonal to Human IgG4